Tyrosine positron emission tomography and protein synthesis rate in pituitary adenoma: Different effects of surgery and radiation therapy

Radiotherapy and Oncology

Volumn 98, Issue 2, 2011, Pages 213-216

  Van Den Bergh, Alfons C M ^a   Pruim, Jan ^a   Links, Thera P ^a   Van Der Vliet, Anton M ^a   Sluiter, Wim ^a   Wolffenbuttel, Bruce H R ^a   Langendijk, Johannes A ^a   Hoving, Eelco W ^a   Dullaart, Robin P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

PET imaging; Pituitary adenoma

Indexed keywords

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESIDUAL SCHIZOPHRENIA; TUMOR VOLUME;

ADENOMA; ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BIOSYNTHESIS; TYROSINE;

EID: 79951851065     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.12.020     Document Type: Article

References (15)

1. A.C.M. Bergh van den, G. Berg van den, and M.A. Schoorl Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma; beneficial effect on local control without additional negative impact on pituitary function and life expectancy Int J Radiat Oncol Biol Phys 67 2007 863 869 (Pubitemid 46215882)
2. N.J.L. Gittoes Radiotherapy for non-functioning pituitary tumors-when and under what circumstances? Pituitary 6 2003 103 108 (Pubitemid 37536862)
3. O. Rodriguez, B. Mateor, and R. Pedraja Postoperative follow-up of pituitary adenomas after trans-sphenoidal resection: MRI and clinical correlation Neuroradiology 38 1996 747 754 (Pubitemid 26390307)
4. J. Parrott, and M.E. Mullins Postoperative imaging of the pituitary gland Top Magn Reson Imaging 16 2005 317 323 (Pubitemid 44350379)
5. M. Bergström, C. Muhr, and P.O. Lundberg PET as a tool in the clinical evaluation of pituitary adenomas J Nucl Med 32 1991 610 615
6. B.J.G. Daemen, R. Zwertbroek, and P.H. Elsinga PET studies with l-[1-11C]tyrosine, l-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromociptine treatment Eur J Nucl Med 18 1991 453 460
7. 11C]-l-deprenyl Neurosurgery 30 1992 855 861
8. B.N.T. Tang, M. Levivier, and M. Heureux 11C-methionine PET for the diagnosis and mangement of recurrent pituitary adenomas Eur J Nucl Med Mol Imaging 33 2006 169 178 (Pubitemid 43152884)
9. C. Muhr Positron emission tomography in acromegaly and other pituitary adenoma patients Neuroendocrinology 83 2006 205 210 (Pubitemid 44578873)
10. K. Ishiwata, W. Vaalburg, and P.H. Elsinga Metabolic studies with L-[1-14C]tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET J Nucl Med 29 1988 524 529
11. W. Vaalburg, H.H. Coenen, and C. Crouzel Amino acids for the measurement of protein synthesis in vivo by PET Nucl Med Biol 19 1992 227 237
12. R.P. Dullaart, S.H. Pasterkamp, and J.A. Beentjes Evaluation of adrenal function in patients with hypothalamic and pituitary disorders; comparison of serum cortisol, urinary free cortisol and the human-corticotrophin releasing hormone test with the insulin tolerance test Clin Endocrinol 50 1999 465 471 (Pubitemid 29193229)
13. 1H magnetic resonance spectroscopy of the response of brain gliomas to radiotherapy Neuroradiology 40 1998 103 108 (Pubitemid 28438801)
14. A.T.M. Willemsen, A. Waarde van, and A.M.J. Paans In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET J Nucl Med 36 1995 411 419
15. B.J.G. Daemen, P.H. Elsinga, and A.M.J. Paans Radiation-induced inhibition of tumor growth as monitored by PET using L-[1-11C]tyrosine and fluorine-18-fluorodeoxyglucose J Nucl Med 33 1992 373 379